| Complication | Evidence | PMID |
| Nephropathy | 1. The CCL2, IL8, CCR5 and MMP9 polymorphisms were found to be associated with the risk of diabetic nephropathy. Frequency of CCL2 II, IL8 -251AA, CCR5 59029AA and MMP9 279Gln/Gln genotypes were significantly higher in DN than in DM group (p<0.05) and associated with an increased risk of nephropathy in both North and South Indian cohorts. | 19357773 |
| Cardiovascular | 1. Although no serum or bone marrow inflammation was seen, HFS increased visceral fat, serum leptin and insulin at week 19 and induced further alterations in lipid profile, serum adiponectin, and TGFbeta1, TIMP1, MMP2, and MMP9, suggesting a prediabetic phenotype and cardiovascular dysfunction at week 27 more pronounced in M than G. | 26175082 |
| Retinopathy | 1. Gelatise B may play an important role in extracellular matrix degradation associated with neovascularization in proliferative diabetic retinopathy 2. Donors with diabetic retinopathy had increased MMP9 activity in their retinal microvessels, the site of histopathology associated with diabetic retinopathy, and this was accompanied by activated H-Ras signaling pathway (Raf-1/ERK). Collectively, these suggest that RaRaf-1/MEK/ERK cascade has an important role in the activation of retinal MMP9 ing in the apoptosis of its capillary cells | 2147483647 |
| Atherosclerosis | 1. In human carotid atherosclerotic plaques, TIMP3 was significantly reduced in subjects with type 2 diabetes, leading to ADAM17 and MMP9 overactivity. Reduced expression of TIMP3 was associated in vivo with SirT1 levels | 19581416 |
